Research  >  About SRI  >  Scientist Profiles  >  Scientists M-R

Scientist profiles M-R

SRI Profiles

Anastasia Oikonomou, MD, PhD

Affiliate scientist

Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room AG 271b
Toronto, ON
M4N 3M5

Phone: 416-480-6100, ext. 1491
Fax: 416-480-5855


  • MD, 1995, Aristoteles University of Thessaloniki, Greece
  • Residency, 2000, diagnostic radiology, Aristoteles University of Thessaloniki, Greece
  • PhD, 2000, medical imaging, University of Democritus, Greece
  • Clinical fellowship, 2001, thoracic imaging, Royal Brompton Hospital, U.K.
  • Clinical fellowship, 2002, thoracic imaging, Ottawa Hospital, Canada
  • Research fellowship, 2002, thoracic imaging, Vancouver General Hospital, Canada
  • Clinical fellowship, 2012, cardiac imaging, Ottawa Heart Institute, Canada

Appointments and Affiliations:

Research Foci:

  • Lung cancer imaging
  • Imaging biomarkers in lung malignancies
  • Lung cancer and interstitial lung diseases
  • Monitoring lung growths and tumours that have spread to the lungs

Research Summary:

The focus of Dr. Oikonomou’s research is on imaging biomarkers in primary and metastatic lung cancers based on CT, MRI and positron emission tomography scans. The research is also focused on evaluating and monitoring lung growths and lung cancer in interstitial lung diseases using novel MRI sequences.

Selected Publications:

See current publications list at PubMed.

  1. Oikonomou A, Salazar P, Zhang Y, Hwang DM, Petersen A, Dmytriw AA, Paul NS, Nguyen ET. Histogram-based models on non-thin section chest CT predict invasiveness of primary lung adenocarcinoma subsolid nodules. Sci Rep. 2019 Apr 12;9(1):6009. doi: 10.1038/s41598-019-42340-5.
  2. Soliman M, Petrella T, Tyrrell P, Wright F, Look Hong NJ, Lu H, Zezos P, Jimenez-Juan L, Oikonomou A. The clinical significance of indeterminate pulmonary nodules in melanoma patients at baseline and during follow-up chest CT. Eur J Radiol Open. 2019 Feb 11;6:85–90. doi: 10.1016/j.ejro.2019.02.003.
  3. Oikonomou A, Khalvati F, Tyrrell PN, Haider MA, Tarique U, Jimenez-Juan L, Tjong MC, Poon I, Eilaghi A, Ehrlich L, Cheung P. Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy. Sci Rep. 2018 Mar 5;8(1):4003. doi: 10.1038/s41598-018-22357-y.
  4. Zhang Y, Oikonomou A, Wong A, Haider MA, Khalvati F. Radiomics-based prognosis analysis for non-small cell lung cancer. Sci Rep. 2017 Apr 18;7:46349. doi: 10.1038/srep46349.
  5. Oikonomou A, Mintzopoulou P, Tzouvelekis A, Zezos P, Zacharis G, Koutsopoulos A, Bouros D, Prassopoulos P. Pulmonary fibrosis and emphysema: Is the emphysema type associated with the pattern of fibrosis? World J Radiol. 2015 Sep 28;7(9):294—305. doi: 10.4329/wjr.v7.i9.294.